Treating subclinical leaflet thrombosis after TAVR has been an ongoing challenge for structural heart clinicians, but recent research has gone a long way toward improving our understanding of this important topic. 

“We can learn from nature, but we have built something that has never been introduced before,” one researcher said. 

These findings come from a new report on recruiting incentives among U.S. physicians and advanced practitioners. Interventional cardiologists earn the second highest starting salary of any specialty, with non-invasive cardiologists not far behind. 

The study's authors explored data from 35 patients who received the TricValve Transcatheter Bicaval Valves System. All patients presented with severe tricuspid regurgitation.

Anita W. Asgar, MD, director, transcatheter valve therapy research at Montréal Heart Institute, discusses advances and new technology for mitral and tricuspid valves at the 2022 Transcatheter Valve Therapies (TVT) meeting. 

Cardiologist Peter Fail, MD, discusses the idea of using shunts to form a passage that enables the left atrium to decompress at rest and during physical activity. The goal is to lower left atrial pressure in heart failure patients.

The new analysis focused on transcatheter edge-to-edge repair and left atrial appendage occlusion procedures.

Researchers compared the new-look drug coated balloon with an uncoated balloon, publishing their findings in JACC: Cardiovascular Interventions.